Westfield Capital Management Co. LP Buys Shares of 237,495 Xenon Pharmaceuticals Inc. (NASDAQ:XENE)

Westfield Capital Management Co. LP bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 237,495 shares of the biopharmaceutical company’s stock, valued at approximately $10,939,000. A number of […]

Related Keywords

Canada ,Wellington ,New Zealand General ,New Zealand ,Sherrington Robin ,Steven Gannon ,First Turn Management ,Citigroup ,Timessquare Capital Management ,Westfield Capital Management Co ,Needham Company ,Xenon Pharmaceuticals Inc ,Quarter For Xenon Pharmaceuticals ,Nasdaq ,Xenon Pharmaceuticals Stock Performance ,Invesco Ltd ,Securities Exchange Commission ,Wellington Management Group ,News Ratings For Xenon Pharmaceuticals Daily ,Xenon Pharmaceuticals ,Royal Bank ,Cantor Fitzgerald ,Westfield Capital Management ,Free Report ,Management Group ,Square Capital Management ,Exchange Commission ,Director Steven Gannon ,Get Free Report ,Pharmaceuticals Inc ,Visit Holdingschannel ,Xenon Pharmaceuticals Daily ,